Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: Involvement in frontostriatal cognitive deficits

Neuroscience

Volumn 90, Issue 3, 1999, Pages 823-832

  Jentsch, J D ^a   Taylor, J R ^a   Elsworth, J D ^a   Redmond Jr , D E ^a   Roth, R H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; Phencyclidine; Prefrontal cortex; Psychotomimetic; Schizophrenia; Serotonin

Indexed keywords

BRAIN MONOAMINE; DOPAMINE; PHENCYCLIDINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; FEMALE; FRONTAL CORTEX; LIMBIC CORTEX; LONG TERM EXPOSURE; MALE; MONKEY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SEROTONINERGIC TRANSMISSION; TASK PERFORMANCE;

ANIMALS; BIOGENIC MONOAMINES; CERCOPITHECUS AETHIOPS; COGNITION; COGNITION DISORDERS; CORPUS STRIATUM; DOPAMINE; FEMALE; FRONTAL LOBE; HALLUCINOGENS; MALE; PHENCYCLIDINE; SEROTONIN; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 0032946806     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00481-3     Document Type: Article

References (53)

1. Allen R. M., Young S. J. Phencyclidine-induced psychosis. Am. J. Psychiat. 135:1978;1081-1084.
2. Arnsten A. F. T., Cai J. X., Murphy B. L., Goldman-Rakic P. S. Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacologia. 116:1994;143-151.
3. Breier A., Malhotra A. K., Pinals D. A., Weisenfeld N. I., Pickar D. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am. J. Psychiat. 154:1997;805-811.
4. Brozoski T. J., Brown R. M., Rosvold H. E., Goldman P. S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science. 205:1979;929-931.
5. Bubser M., Schmidt W. J. 6-OHDA lesions of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze. Behav. Brain Res. 37:1990;157-168.
6. Cosgrove J., Newell T. G. Recovery of neuropsychological functions during reduction in use of phencyclidine. J. clin. Psychol. 47:1991;159-169.
7. Daniel D. G., Berman K. F., Weinberger D. R. The effect of apomorphine on regional cerebral blood flow in schizophrenia. J. Neuropsychiat. 1:1989;377-384.
8. Daniel D. G., Weinberger D. R., Jones D. W., Zigun J. R., Coppola R., Handel S., Bigelow L. B., Goldberg T. E., Berman K. F., Kleinman J. E. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J. Neurosci. 11:1991;1907-1917.
9. Davis K. L., Kahn R. S., Ko G., Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiat. 148:1991;1474-1486.
10. Deutch A. Y., Clark W. A., Roth R. H. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res. 521:1990;311-315.
11. Deutch A. Y. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J. neural Transm. 36:1992;61-89.
12. Diamond A., Goldman-Rakic P. S. Evidence for involvement on prefrontal cortex in cognitive changes during the first year of life: comparison of performance of human infants and rhesus monkeys on a detour task with transparent barrier. Soc. Neurosci. Abstr. 11:1985;832.
13. Diamond A., Zola-Morgan S., Squire L. R. Successful performance by monkeys with lesions of the hippocampal formation on A-B and object retrieval, two tasks that mark developmental changes in human infants. Behav. Neurosci. 103:1989;526-537.
14. Dias R., Robbins T. W., Roberts A. C. Dissociation in prefrontal cortex of affective and attentional shifts. Nature. 380:1995;69-72.
15. Dias R., Robbins T. W., Roberts A. C. Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset. Behav. Neurosci. 110:1996;872-886.
16. Dias R., Robbins T. W., Roberts A. C. Dissociable forms of inhibitory control within prefrontal cortex with an analog of the Wisconsin Card Sort test - restriction to novel situations and independence from on-line processing. J. Neurosci. 17:1997;9285-9297.
17. Dolan R. J., Fletcher P., Frith C. D., Friston K. J., Frackowiak R. S. J., Grasby P. M. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia. Nature. 378:1995;180-182.
18. Goldman P. S., Rosvold H. E., Vest B., Galkin T. W. Analysis of the delayed-alternation deficit produced by dorsolateral prefrontal lesions in the rhesus monkey. J. comp. physiol. Psychol. 77:1971;212-220.
19. Goldman-Rakic P. S. (1987) Circuitry of the frontal cortex and the regulation of behavior by representational knowledge. In Handbook of Physiology, the Nervous System (eds Plum F. and Mountcastle V. M.), Vol. 5, pp. 373-417. American Physiological Society, Bethesda.
20. Goldman-Rakic P. S. (1991) Prefrontal cortical dysfunction in schizophrenia: relevance of working memory. In Psychopathology and the Brain (eds Carroll B. J. and Barrett J. E.), pp. 1-23. Raven, New York.
21. Grace A. A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience. 41:1991;1-24.
22. Hertzman M., Reba R. C., Kotlyarove E. V. Single photon emission computerized tomography in phencyclidine and related drug abuse. Am. J. Psychiat. 147:1990;255-256.
23. Iversen S. D., Mishkin M. Perseverative intereference in monkeys following selective lesions of the inferior prefrontal convexity. Expl Brain Res. 11:1970;376-386.
24. Javitt D. C., Zukin S. R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiat. 148:1991;1301-1308.
25. Jentsch J. D., Elsworth J. D., Redmond D. E. Jr., Roth R. H. Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966. J. Neurosci. 17:1997;1769-1776.
26. Jentsch J. D., Redmond D. E. Jr., Elsworth J. D., Taylor J. R., Youngren K. D., Roth R. H. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science. 277:1997;953-955.
27. Jentsch J. D., Tran A. N., Le D., Youngren K. D., Roth R. H. Subchronic exposure to phencyclidine reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology. 17:1997;92-99.
28. Jentsch J. D., Elsworth J. D., Taylor J. R., Redmond D. E. Jr., Roth R. H. Dysregulation of mesoprefrontal dopamine neurons induced by acute and repeated phencyclidine administration in the non-human primate: implications for schizophrenia. Adv. Pharmac. 42:1998;810-814.
29. Jentsch J. D., Taylor J. R., Roth R. H. Subchronic exposure to phencyclidine increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion. Neuropsychopharmacology. 19:1998;105-113.
30. Kane J., Honigfeld G., Singer J., Meltzer H. Y. Clozapine for the treatment-resistent schizophrenic. A double-blind comparison with chlorpromazine. Archs gen. Psychiat. 45:1988;789-796.
31. Knable M. B., Weinberger D. R. Dopamine, the prefrontal cortex and schizophrenia. J. Psychopharmac. 11:1997;123-131.
32. Kolachana B. S., Saunders R. C., Weinberger D. R. Augmentation of prefrontal cortical monoaminergic activity inhibits dopamine release in the caudate nucleus: an in vivo neurochemical assessment in the rhesus monkey. Neuroscience. 69:1995;859-868.
33. Kolb B. Functions of frontal cortex of the rat: a comparative review. Brain Res. 320:1984;65-98.
34. Lee M. A., Thompson P. A., Meltzer H. Y. Effects of clozapine on cognitive function in schizophrenia. J. clin. Psychiat. 55(Suppl. B):1994;82-87.
35. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. J. biol. Chem. 193:1951;265-275.
36. Moll L., Kuypers H. G. J. M. Premotor cortical ablations in monkeys: contralateral changes in visually-guided reaching behavior. Science. 198:1977;317-319.
37. Murase S., Grenhoff J., Chouvet G., Gonon F., Svensson T. H. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci. Lett. 157:1993;53-56.
38. Robbins T. W. The case for frontostriatal dysfunction in schizophrenia. Schizophr. Bull. 16:1990;391-402.
39. Robbins T. W. Dissociating executive functions of the prefrontal cortex. Phil. Trans. R. Soc. 351:1996;1463-1471.
40. Roberts A. C., DeSalvia M. A., Wilkinson L. S., Collins P., Muir J. L., Everitt B. J., Robbins T. W. 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analogue of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine. J. Neurosci. 14:1994;2531-2544.
41. Rosin D. L., Clark W. A., Goldstein M., Roth R. H., Deutch A. Y. Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in subcortical dopamine systems in the rat. Neuroscience. 48:1992;831-839.
42. Sawaguchi T., Goldman-Rakic P. S. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science. 251:1991;947-950.
43. Schneider J. S., Kovelowski C. J. Chronic exposure to low doses of MPTP: I. Cognitive deficits in motor asymptomatic monkeys. Brain Res. 519:1990;122-128.
44. Taber M. T., Fibiger H. C. Electrical stimulation of the medial prefrontal cortex increases dopamine release in the striatum. Neuropsychopharmacology. 9:1993;271-275.
45. Taber M. T., Fibiger H. C. Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors. J. Neurosci. 15:1995;3896-3904.
46. Taylor J. R., Elsworth J. D., Roth R. H., Sladek J. R., Redmond D. E. Jr. Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys. Brain. 113:1990;617-637.
47. Taylor J. R., Roth R. H., Sladek J. R., Redmond D. E. Jr. Cognitive and motor deficits in the performance of an object retrieval/detour task with barrier in monkeys treated with MPTP: long-term performance and effect of transparency of the barrier. Behav. Neurosci. 104:1990;564-576.
48. Watanabe M., Kodama T., Hikosaka K. Increase in extracellular dopamine in primate prefrontal cortex during a working memory task. J. Neurophysiol. 78:1997;2795-2798.
49. Weinberger D. R., Berman K. F., Zec R. F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia: I. Regional cerebral blood flow evidence. Archs gen. Psychiat. 43:1986;114-125.
50. Weinberger D. R., Berman K. F., Illowsky B. P. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia: III. A new cohort and evidence for a monoaminergic mechanism. Archs gen. Psychiat. 45:1988;609-615.
51. Weinberger D. R., Berman K. F. Prefrontal function in schizophrenia: confounds and controversies. Phil. Trans. R. Soc. 351:1996;1495-1503.
52. Wu J. C., Buchsbaum M. S., Bunney W. E. Positron emission tomography study of phencyclidine users as a possible drug model of schizophrenia. Jap. J. Psychopharmac. 11:1991;47-48.
53. Youngren K. D., Moghaddam B., Bunney B. S., Roth R. H. Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatment. Neurosci. Lett. 165:1994;41-44.